Skip to main content
Caplight Logo









BIOND Solutions

BIOND Solutions

Private
DelftHealthcare & Life Scienceshttps://www.gobiond.com/

Last Round

Series A

Mar 8, 2022

Total Funding Raised

$4.29M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

BIOND Solutions is a biotechnology company that develops a customizable organ-on-chip platform designed to nourish, stimulate, and monitor cells and complex 3D tissues for research applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

organ-on-chipOOCmicrofluidic chip3D cell culturemicrophysiological systemdrug discoveryNAMsanimal testing alternativeNew Approach Methodologiestoxicology testingdisease modelinglab-on-a-chipcell-based assayorganoid culturepreclinical researchmuscle-on-a-chipbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIOND Solutions Comparables

Compare BIOND Solutions with similar companies based on industry and business-model similarity.

BIOND Solutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beonchip
89%
AlveoliX AG
86%
Emulate
86%

BIOND Solutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 8, 2022
SeedOct 7, 2020

BIOND Solutions Investors

Notable investors and investment history

BIOND Solutions investors
InvestorRounds
FORWARD.oneSeries A
InnovationQuarterSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 13, representing 650% of headcount.

  • May 1, 2025

    Monthly visitors increased 214% MoM, reaching 1K.

BIOND Solutions Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BIOND Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BIOND Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersDelft
Employee Range2
Year Founded2017
Last FundingMar 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?